General Information
Revision date
2014-06-19
Product name
ALBUMIN (HUMAN) U.S.P.; ALBUTEIN -5,-20
Product Synonyms
ALBUMIN (HUMAN) U.S.P.; ALBUTEIN® -5,-20
Chemical name
Sterile aqueous solution of human plasma proteins
CAS No.
N
1.2.1 Relevant identified uses
sage: Hypovolemia; Cardiopulmonary
Icons in SDS
Company Information
company name
GRIFOLS Biologicals In
Section 2
SECTION 2: Hazards identification
29 CFR 1910.1200) Globally Harmonized System of Classification and Labeling of Chemicals (GHS) No ha zards are expected from using this product. This product is not regulated under the United Nations Globally Harmonized System for the Classification and Labeling of Hazardous Chemicals (GHS) 2006 vers ion; European Directive 67/648/EEC; and U.S
EU Classification
The product is not regulated under European Directive 67/648/EEC O SHA CLASSIFICATION The product is not regulated under U.S.
Principle Routes of Exposure
Accidental, Eye contact, Skin contact, Ingestion, Appropriate route of entry - Intravenous M
Medical Conditions Generally Aggravated by Exposure
None known P
Potential health effects
INHALATION: ACUTE (IMMEDIATE): None know n C HRONIC (DELAYED): None known SKIN: ACUTE (IMMEDIATE): None known C HRONIC (DELAYED): None known EYE: ACUTE (IMMEDIATE): None known C HRONIC (DELAYED): None known INGESTION: ACUTE (IMMEDIATE): None known C HRONIC (DELAYED): None known MUTAGENIC EFFECTS: None known C ARCINOGENIC EFFECTS: None known Page 2 of 6 ALBUMIN (HUMAN) U.S.P., ALBUTEIN® -5, -20, -25% SOLUTION R EPRODUCTIVE EFFECTS: None known O
Other Health Effects
This product is prepared from pooled human plasma. Each plasma donation has been tested for the absence of antibodies ag ainst HIV-1, HIV-2 and Hepatitis C and the absence of surface antigens for H epatitis B. Additionally, mini-pools of plasma donations have been tested for the absence of the HIV-1, Hepatitis C and Hepatitis B viruses using Polymerase Chain Reaction (PCR) technology. The product has also undergone separate manufacturing processes to remove and/or inactivate enveloped and non-enveloped viruses. However, as with all human derived products, the risk of infectivity due to known or yet unknown pathogens cannot be totally eliminated or ensured. See Section 12 for Ecological Information